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Background: Some previous studies have postulated an association between migraine and excessive daytime
sleepiness (EDS). This study evaluated the association of EDS with migraine and headache frequency in a general
population, after adjusting for potential confounding variables.
Methods: The study was a postal survey of a random age and gender-stratified sample of 40,000 persons aged 20
to 80 years old drawn by the National Population Register in Norway. The questionnaire included questions about
migraine, headache, the Epworth sleepiness scale (ESS) and various comorbidities. EDS was defined as ESS > 10. The
association of EDS and migraine/headache were analysed by bivariate and multivariable logistic regression analyses.
Results: A total of 21,177 persons responded to the ESS and were included in the analyses. The odds ratio (OR) for
EDS was increased for migraineurs (1.42 (95% CI 1.31─1.54), p < 0.001) compared to non-migraineurs; however, this
finding was not significant after adjustment for a number of possible confounders. EDS increased with increasing
headache frequency, with an OR of 2.74 (95% CI 2.05─3.65), p < 0.001) for those with headache on >179 days per
year compared to those without headache in multivariable analysis.
Conclusions: In a general population, the odds for EDS increased significantly with the headache frequency,
irrespective of migraine status. EDS was not associated with reported migraine in multivariable analysis.
Keywords: Epidemiology, Excessive daytime sleepiness, Headache, MigraineBackground
Headache is the most common type of pain experienced
by man, but receives little attention, possibly due to the
often mild symptoms, and because most people rarely
consult their physician due to headache [1]. Almost
everyone experience tension-type headache once in a
while, and migraine affects 10–20% of the general popu-
lation [2, 3]. About 3% of the world population have
chronic headache, i.e. mainly chronic tension-type head-
ache or chronic migraine [4, 5].
Persons with headache and/or migraine often complain
of sleepiness, a symptom with high clinical and public* Correspondence: knut.stavem@medisin.uio.no
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the Creative Commons license, and indicate ifhealth importance due to increased risk for accidents, de-
creased productivity and impaired quality of life [6–9]. Ex-
cessive daytime sleepiness (EDS) is experienced by
8─30% of the general population [10–13]. Despite the
considerable burden of EDS, it is still under-reported,
under-diagnosed and under-treated among those with
chronic pain as well as in the general population [14–16].
Some clinic-based [17–20] or population-based [21]
studies have proposed an association between migraine
and EDS. Recently a large population-based study re-
ported an association between migraine and EDS in bi-
variate analysis, but this association was weakened in
multivariable analysis and became non-significant when
adjusting for anxiety, depression, sleep duration and a
score for sleep quality [22]. Moreover, whether EDS is
associated with headache frequency in migraineurs var-
ies between studies [21, 22].is distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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of EDS with migraine and headache frequency in an age
and gender-stratified general population sample, after
adjusting for possible confounders.
Methods
Study design and sample
An age and gender-stratified random sample of 40,000
persons aged 20─80 years old were drawn by the Na-
tional Population Register of Statistics Norway. Each of
the ages 30, 35, 40, 45, 50, 55 and 60 years included
2,000 persons of each gender, while the remaining ages
included 1,000 persons of each gender. The participants
were residing in Akershus, Hedmark or Oppland
County. The sample size was reduced to 38,871 because
of error in the address list (n = 1,024), multi-handicap (n
= 4), dementia (n = 23), insufficient Norwegian language
skills (n = 3) and deceased (n = 75). The three counties
have both rural and urban areas, and Akershus County
is situated in close proximity to Oslo. Details of the
study have previously been presented [23].
Postal survey
All participants received a mailed questionnaire with a
standard letter containing information about the project.
Apart from ensuring confidentiality and emphasising the
importance of participation, it was stated that the objective
was to study sleepiness during daytime. If the question-
naire evoked no response, a second mail was issued. The
replies could either be on paper or web-based. The data
were collected between February and August 2006. All
questionnaires were scanned using TeleForm version 9
(Cardiff Software Ltd, Cambridge, UK).
Migraine and headache
The questions: “How many days during the last year
have you had headache? (0 days, 1─11 days,
12─30 days, 31─84 days, 85─179 days or ≥180 days)”,
and “Have you ever had migraine? (yes or no)” were
used to screen for headache frequency and migraine. We
applied the International Classification of Headache Dis-
orders (ICHD-II) definitions slightly modified, i.e. no
headache is 0 headache days within the last year, infre-
quent headache is 1–11 headache days within the last
year, frequent headache is 12─179 headache days within
the last year, while chronic headache is 180 days or more
within the last year [24]. The term non-migraineurs de-
scribes those without migraine, independent of whether
they reported headache or not.
Daytime sleepiness and average sleep time
Daytime sleepiness was assessed by the Epworth Sleepi-
ness Scale (ESS). The ESS is a standardized question-
naire which describes eight daily situations in which therespondents estimate their likelihood of dozing off on a
scale of 0 to 3, i.e. 0 = no chance of dozing, 1 = slight
chance of dozing, 2 =moderate chance of dozing and 3
= high chance of dozing [25]. The ESS score thereby
ranges from 0 to 24, and the results were dichotomized
into scores ≤10 and >10, the latter is considered to rep-
resent clinically significant EDS [26]. A question of aver-
age sleep time duration during the night was answered
in hours and minutes and was categorized into three
classes: short (<6 h), normal (6─8 h) and long (>8 h)
sleep duration. In Norway, the ESS has exhibited proper-
ties in line with other language versions of the question-
naire [27].
Smoking status and body mass index
Smoking status was assessed with the item “How many
cigarettes do you usually smoke per day?”, coded as
none, 1─10, 11─20, >20 for the analyses. Body mass
index (BMI) in kg/m2 was calculated from self-reported
weight and height.
Comorbidity
To screen for depression, we asked the question: “Have
you felt depressed or experienced diminished interest or
pleasure in activities you usually enjoy?” This is a com-
bination of two questions, where a “yes” answer to either
of the two questions was considered a positive test [28].
The replies were dichotomized, i.e. never or rarely, 1─2
times a month, 1─2 times a week or 3─4 times a week
were classified as no depression, while almost daily was
classified as depression.
The participants also responded to items about other
comorbidities: previous myocardial infarction (yes or
no), stroke (yes or no), current/previous angina pectoris
(yes or no), asthma (yes or no), allergy (yes or no),
hypertension (yes, no or unknown), or diabetes (yes or
no). Finally, they responded to an item about ever having
had treatment for a sleep disorder (yes or no).
Statistical analyses
Descriptive statistics are presented using the mean (SD)
or number (%). Groups were compared using the chi-
square test.
Prevalence estimates are presented with cross-tables.
To assess possible effect modification, the homogeneity
of odds ratios (OR) for EDS in migraine vs. non-
migraine was tested in stratified analyses using the chi-
square test.
The association of EDS with migraine and headache
frequency was analysed by bivariate and multivariable lo-
gistic regression analyses with EDS (ESS > 10 = 1, ESS ≤
10 = 0) as the dependent variable. The six independent
variables migraine, headache frequency, age, gender,
BMI, and depression were included in the model. The
Table 1 Descriptive statistics for survey respondents, number
(%) unless otherwise stated
N
Age in years, mean (SD) 21,177 50.5 (15.6)
Gender, women 21,177 11,120 (53)
Epworth sleepiness scale score, mean (SD) 21,177 6.7 (4.0)
Epworth sleepiness scale score >10 21,177 3,501 (17)
Migraine 19,833 5,258 (27)






180 days or more 575 (3)
Body mass index in kg/m2, mean (SD) 20,818 25.8 (4.2)
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models, (2) Multivariable models with the six variables
mentioned above, (3) Multivariable models as (2) with
the addition of the variables of allergy, angina pectoris,
asthma, diabetes, hypertension, myocardial infarction
and stroke, and (4) Multivariable models as (3) with the
addition of the variables cigarette smoking, nightly sleep
duration, and treatment for sleep disorder. Missing
values were not imputed, and deletion of cases in the
models was listwise.
Tests for multiplicative interactions were conducted be-
tween migraine*gender, headache frequency*gender, and
migraine*headache frequency. Finally, model (3) was repli-
cated in subsets of the respondents: non-migraineurs,
migraineurs, men, and women.
All statistical analyses were performed using Stata ver-
sion 14.1 (StataCorp, College Station, TX). We chose a
5% significance level, using two-sided tests.Comorbidity
Symptoms of depression 20,476 1,401 (7)
Myocardial infarction 20,686 814 (4)
Stroke 19,938 536 (3)
Angina pectoris 20,681 978 (5)Ethical issues
The project was approved by The Regional Committees
for Medical Research Ethics and the Norwegian Social




Diabetes 20,685 934 (5)
Allergy 20,121 6,564 (33)
Asthma 19,156 2,287 (12)
Treated for sleep disorder 20,749 1,251 (6)





Average nightly hours slept, mean (SD) 20,907 7.0 (1.1)




The overall response rate was 54.5% (21,177/38,871).
The respondents had a mean (SD) age of 50.5 (15.6)
years and comprised 52.5% women (Table 1). Complete
information on headache and migraine was reported by
89.4% of women and by 88.0% of men. Regarding replies
to the ESS, 4.7% of women and 3.3% of men had missing
values in one question, 0.7% of women and 0.6% of men
had missing values in two questions, while 1.2% of
women and 0.7% of men had missing values in three or
more questions.
The 1-year prevalence of headache was 77.2%; 84.0%
(8,872/10,558) in women and 69.6% (6,590/9,463) in
men. The lifetime prevalence of migraine was 26.5%;
34.1% (3,562/10,441) in women and 18.1% (1,696/9,392)
in men (p < 0.001). In the total population the mean
(SD) ESS score was 6.7 (4.0); among migraineurs 7.1
(4.2) (n = 5,258) and non-migraineurs 6.5 (3.9) (n =
14,575). The ESS scores according to migraine status
(Fig. 1) and headache frequency (Fig. 2) showed skewed
distributions in most subgroups.
Among migraineurs, non-migraineurs, and those
with a missing response to the migraine item, the
prevalence of EDS increased with headache frequency
in all three groups (Table 2). The overall prevalence of
EDS among the respondents (n = 21,177) was 17%, and
it was 20% among migraineurs, 15% among non-
migraineurs, and 19% among those with missing value
on the migraine item.There was no indication of heterogeneity of the ORs
for EDS in migraine vs. non-migraine, or women vs.
men in strata according to headache frequency (Table 3).
In bivariate logistic regression analysis, the odds ratio
(OR) for having EDS was higher among migraineurs
than non-migraineurs, and the OR for EDS increased











Epworth sleepiness scale score
Fig. 1 Histogram of the frequency of Epworth sleepiness scale scores for participants according to migraine or non-migraine status
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ship between migraine and EDS was weaker than in bi-
variate analysis, while the pattern of increasing OR for
EDS with increasing headache frequency persisted in
models after adjusting for age, BMI, depression, and gen-
der (Table 4). Adjusting for additional potential comorbid-
ities in two steps did not change this pattern (Table 4).
Interaction terms between migraine*gender, headache fre-
quency*gender, and migraine*headache were statistically
not significant and were left out in the models.
In multivariable analysis in strata of the respondents,
the pattern of ORs was consistent across migraineurs
and non-migraineurs after adjusting for headache fre-
quency, age, BMI, depression, gender and other comor-
bidities, and across women and men after adjusting for
migraine, headache frequency, age, BMI, depression and
other comorbidities (Table 5).
Discussion
This population-based cross-sectional study has demon-














Fig. 2 Histogram of the frequency of Epworth sleepiness scale scores for p
of days per month)bivariate analysis, although this association was weak-
ened and eventually disappeared in multivariable ana-
lysis, and (2) an association between headache frequency
and EDS, which was consistent after adjustment for nu-
merous potential confounders, and also when the ana-
lysis was replicated in subsets of the study population,
i.e. among migraineurs, non-migraineurs, women or
men.
Overall 17% met the criteria for having EDS, which is
in line with that of a previous Norwegian telephone sur-
vey of a general population [29]. Our 20% prevalence of
EDS in migraineurs was identical to that of Korean
migraineurs from the general population [22]. The EDS
prevalence in European clinic populations was 14% in
those with episodic migraine [18] and 20% in chronic
migraine [20], while it was substantial higher in an
American clinic population, i.e. 32% in episodic migrai-
neurs and 40% in chronic migraineurs [17]. The higher
prevalence in the American study may partly be ex-
plained by a slightly higher mean BMI and lower ESS
cut off, i.e. ≥ 10 rather than >10 in the present and12 18 24 0 6 12 18 24
-11 days 12-30 days
-179 days 180 days or more
ess scale score
articipants according to categories of headache frequency (in number
Table 2 Prevalence of excessive daytime sleepiness (EDS), defined as Epworth sleepiness scale score >10, according to migraine and
headache frequency
Non-migraine Migraine Missing migraine item Total
Headache frequency, days last year N n (%) N n (%) N n (%) N n (%)
None 3,814 413 (11) 390 56 (14) 355 56 (16) 4,559 525 (12)
1–11 6,159 862 (14) 1,568 228 (15) 382 59 (15) 8,109 1,149 (14)
12–30 2,040 378 (19) 1,302 238 (18) 205 41 (20) 3,547 657 (19)
31–84 1,019 227 (22) 1,087 271 (25) 174 42 (24) 2,280 540 (24)
85–179 411 115 (28) 482 139 (29) 58 14 (24) 951 268 (28)
≥180 219 76 (35) 294 102 (35) 62 22 (35) 575 200 (35)
Missing 913 124 (14) 135 22 (16) 108 15 (14) 1,156 162 (14)
Total 14,575 2,196 (15) 5,258 1,056 (20) 1,236 234 (19) 21,177 3,501 (17)
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100 person with episodic and chronic migraine, respect-
ively, while the American clinic study included 72 per-
sons with episodic migraine and 128 persons with
chronic migraine, providing relative broad confidence in-
tervals for the EDS prevalence, i.e. 14% (8–22%), 20%
(13–29%), 32% (25–48%) and 40% (31–49%).
The present study found an association between mi-
graine and EDS in bivariate analysis, which was weaker
in the multivariable analyses and disappeared when
adjusting for all potential confounders, a finding similar
to that of The Korean population-based study when
adjusting for anxiety, depression, sleep duration and
Pittsburgh Sleep Quality index score [22]. These findings
are in concert with another population-based study
reporting increased odds of EDS in migraineurs com-
pared with headache-free individuals after adjustment
for age, sex and sleep-promoting medication [21]. The
findings are also supported by a case–control study of
episodic migraine [18, 20], as well as a study including
370 migraineurs and 119 non-migraineurs [20]. The lat-
ter study found a statistically significant association of
chronic migraine and EDS with an OR of 3.9 (95% CI
1.5.–10.2), although the mean ESS score was notTable 3 Odds ratios and 95% confidence intervals (95% CI) for havin
to non-migraineurs, and men versus women. Stratified analyses acco
Migraine vs. non-migraine








Test of homogeneity of odds ratios: Chi2(6) = 4.69, P = 0.58significant different between those with chronic migraine
and healthy controls [20].
In contrast, one study reported a statistically signifi-
cant association between migraine and sleep problems
after adjusting for both lifetime and current anxiety
and mood disorders [30]. This was a controlled study
using a systematic assessment of migraine, sleep prob-
lems and anxiety and mood disorders with interviews,
in contrast to the present, larger questionnaire-based
survey.
In the present study, the prevalence of EDS increased
with headache frequency, independent of migraine sta-
tus, in line with a previous general population study
[21], although in the latter study the increased ORs for
EDS with increasing headache frequency were statisti-
cally not significant. Therefore, it is possibly the fre-
quency of the pain rather than migraine or tension-type
headache in itself that is associated with EDS.
There was no evidence of effect modification of gender
or headache frequency on the association of migraine
with EDS, or of gender on the association of headache
frequency with EDS, as indicated by the homogeneity of
the ORs and the lack of significant interactions in the re-
gression models.g excessive daytime sleepiness (EDS) for migraineurs compared
rding to headache frequency categories
Men vs. women
P Odds ratio (95% CI) P
0.035 1.25 (1.03─1.51) 0.026
0.58 1.35 (1.19─1.53) <0.001
0.86 1.34 (1.13─1.59) <0.001
0.152 1.36 (1.11─1.66) 0.003
0.78 1.21 (0.90─1.64) 0.21
1.00 0.91 (0.63─1.32) 0.62
0.42 1.37 (0.98─1.91) 0.068
Chi2(6) = 4.73, P = 0.58







N 19,833─21,177 18,027 15,299 12,369
Odds ratio (95%CI) P Odds ratio (95%CI) P Odds ratio (95%CI) P Odds ratio (95%CI) P
Migraine
No 1 1
Yes 1.42 (1.31─1.54) <0.001 1.11 (1.01─1.22) 0.032 1.11 (1.00─1.23) 0.044 1.08 (0.96─1.21) 0.196
Headache frequency, days per year
None 1 1 1 1
1─11 1.27 (1.14─1.42) <0.001 1.18 (1.05─1.34) 0.009 1.23 (1.07─1.41) 0.003 1.17 (1.00─1.36) 0.05
12─30 1.75 (1.54─1.98) <0.001 1.54 (1.33─1.78) <0.001 1.53 (1.31─1.80) <0.001 1.50 (1.25─1.79) <0.001
31─84 2.38 (2.09─2.72) <0.001 2.07 (1.77─2.42) <0.001 2.02 (1.70─2.40) <0.001 2.00 (1.65─2.43) <0.001
85─179 3.02 (2.55─3.57) <0.001 2.53 (2.08─3.06) <0.001 2.39 (1.93─2.96) <0.001 2.26 (1.77─2.87) <0.001
≥180 4.10 (3.37─4.98) <0.001 3.12 (2.49─3.92) <0.001 3.12 (2.42─4.02) <0.001 2.74 (2.05─3.65) <0.001
Age, per 10 years 0.85 (0.83─0.87) <0.001 0.87 (0.85─0.90) <0.001 0.88 (0.85─0.91) <0.001 0.88 (0.84─0.91) <0.001
Gender
Women 1 1 1 1
Men 1.10 (1.02─1.18) 0.01 1.26 (1.16─1.37) <0.001 1.21 (1.11─1.33) <0.001 1.22 (1.10─1.35) <0.001
Body mass index, per kg/m2 1.05 (1.04─1.06) <0.001 1.05 (1.04─1.06) <0.001 1.04 (1.03─1.05) <0.001 1.04 (1.02─1.05) <0.001
Symptoms of depression
No 1 1 1 1
Yes 2.99 (2.66─3.36) <0.001 2.45 (2.15─2.80) <0.001 2.48 (2.13─2.88) <0.001 2.20 (1.86─2.62) <0.001
aadjusted for additional potential confounders allergy, angina pectoris, asthma, diabetes, hypertension, myocardial infarction and stroke
badjusted for additional potential confounders (as above) + cigarette smoking (0, 1─10, 11─20, >20 per day), nightly sleep (<6 h, 6─8 h, >8 h) and previous
treatment for sleep disorder
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large population-based survey. Secondly, the multivari-
able analyses were conducted in three consecutive steps
and adjusted for an increasing number of possible con-
founders in each step.
Several potential limitations of this study should be
mentioned. The response rate was relatively low; however,
it was comparable to that of some other sleep-related epi-
demiologic studies [29, 31] and higher than in recent
population-based studies of headache and sleep [21, 22].
The present study defined EDS as ESS > 10, in line
with the recommendation of the developer of the ESS
[32], recent epidemiological studies [33–35] and a recent
population-based study of headache and sleep [22]. In
contrast, for unknown reasons, most previous studies of
the association of migraine or headache frequency with
EDS defined EDS as ESS ≥10 [17–21], which would lead
to a higher prevalence of EDS. The ESS is widely used in
evaluating subjective daytime sleepiness [25, 36]. How-
ever, the ESS has been criticized because it shows little
association with objective measures, such as the multiple
sleep latency test (MSLT) [37–39]. The large number of
participants in this study precluded the use of MSLT for
more comprehensive assessment of daytime sleepiness.Another potential limitation is that the data reported
in the present study were self-reported. This study asked
about lifetime prevalence of migraine. The single ques-
tion about lifetime occurrence of migraine, which was
used, has previously been evaluated against a clinical
interview by two physicians in another Norwegian sur-
vey in eastern Akershus County, reporting a raw agree-
ment rate of 0.81 and kappa (κ) of 0.62, which is
considered to be a good agreement [23]. Two previous
epidemiological surveys used the same screening ques-
tion for migraine as in the present study, and the ob-
served agreement rates were 0.92 and 0.94, and κ were
0.77 and 0.81, respectively [2, 40]. Due to the high num-
ber of participants in our survey, it was not feasible to
apply the gold standard, i.e. a clinical interview by a
physician/neurologist with expertise in headache diag-
nostics. The current study did not investigate the effect
of EDS on clinical characteristics of migraine, which
would require more detailed clinical information than is
possible in a questionnaire-based general population
survey.
Single questions about tension-type headache and its
frequency have been compared with a clinical interview,
and the agreement was good [3, 40]. We think our
Table 5 Odds ratios and 95% confidence intervals (95% CI) for having excessive daytime sleepiness (EDS), multivariable logistic
regression analysisa in strata of the population
Migraineurs Non-migraineurs Men Women
N 4,126 11,173 7,313 7,986
Odds ratio (95%CI) P Odds ratio (95%CI) P Odds ratio (95%CI) P Odds ratio (95%CI) P
Migraine
No - - 1 1
Yes - - 1.18 (1.01─1.38) 0.041 1.07 (0.94─1.22) 0.31
Headache frequency, days per year
None 1 1 1
1─11 0.93 (0.63─1.37) 0.73 1.27 (1.09─1.47) 0.002 1.32 (1.11─1.57) 0.001 1.09 (0.86─1.37) 0.48
12─30 1.21 (0.82─1.79) 0.34 1.58 (1.32─1.89) <0.001 1.63 (1.31─2.03) <0.001 1.37 (1.07─1.75) 0.013
31─84 1.74 (1.17─2.57) 0.006 1.92 (1.55─2.37) <0.001 2.30 (1.79─2.94) <0.001 1.74 (1.34─2.25) <0.001
85─179 1.90 (1.24─2.91) 0.003 2.52 (1.91─3.34) <0.001 2.33 (1.65─3.30) <0.001 2.21 (1.64─2.96) <0.001
≥180 2.72 (1.71─4.30) <0.001 2.92 (2.04─4.19) <0.001 2.43 (1.57─3.77) <0.001 3.21 (2.30─4.50) <0.001
Age, per 10 years 0.90 (0.84─0.95) 0.001 0.87 (0.84─0.91) <0.001 0.92 (0.88─0.97) 0.001 0.85 (0.81─0.89) <0.001
Sex
Women 1 1 - -
Men 1.31 (1.11─1.54) 0.002 1.18 (1.06─1.32) 0.003 - -
Body mass index, per kg/m2 1.04 (1.02─1.05) <0.001 1.04 (1.03─1.06) <0.001 1.05 (1.03─1.06) <0.001 1.04 (1.03─1.05) <0.001
Symptoms of depression
No 1 1 1
Yes 2.18 (1.70─2.79) <0.001 2.66 (2.21─3.21) <0.001 2.57 (2.05─3.22) <0.001 2.43 (1.99─2.97) <0.001
aadjusted for additional potential confounders allergy, angina pectoris, asthma, diabetes, hypertension, myocardial infarction and stroke
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the single question about tension-type headache, be-
cause the term headache is known by everybody, while
some subjects may not know what tension-type head-
ache is. Similarly, we think the frequency report on
headache is likely to be precise.
The data on headache frequency was based on head-
ache during the last year, which is likely to be less sub-
ject to recall bias as compared to headache earlier in life.
Moreover, the single question about self-reported de-
pression might be less precise than a more extensive
questionnaire or diagnostic interview. However, the
combination of the two questions into one item has
been shown to have a sensitivity of 96% (95% CI
90─99%) and specificity of 57% (95%CI 53─62%) in re-
lation to major depression [28]. This compares with a
sensitivity of 89─96% and specificity 51─72%, when
ascertained with more extensive questionnaires [28].
The present study did not assess the quality of sleep,
or the use of analgesics that may be associated with
headaches and EDS, or β-blockers that may be used in
prophylactic treatment of migraine and may be associ-
ated with EDS. However, only a small minority of
migraineurs use β-blockers.
The focus of this paper was on the association of mi-
graine and headache frequency with EDS, and not on ageneral prediction model for EDS. Therefore, we have
focused on factors that may confound the association of
migraine and/or headache frequency with EDS, and on
possible effect modification between some of these vari-
ables. EDS depends on several factors known to interfere
with the sleep-awake cycle, while headache and migraine
are mainly known to vary with gender. For example, caf-
feine, alcohol, employment including nightshifts, restless
legs syndrome, concomitant urological diseases, men-
struation and thyroid hormones may be associated with
EDS. However, based on the literature, we are not aware
of firm evidence for an association of these factors with
migraine or tension-type headache, and if such an asso-
ciation exists it is most likely of limited importance.Conclusions
This study showed that EDS was associated with an in-
crease in headache frequency in both migraineurs and
non-migraineurs. In contrast, the association between
migraine and EDS disappeared after adjustment for a
number of confounders.
Abbreviations
EDS: Excessive daytime sleepiness; ESS: Epworth sleepiness scale;
ICHD: International classification of headache disorders; MSLT: Multiple sleep
latency test; SD: Standard deviation
Stavem et al. The Journal of Headache and Pain  (2017) 18:35 Page 8 of 9Acknowledgements
None.
Funding
This study was supported by a grant from South-East Norway Regional
Health Authority, grant number 2004219.
Availability of data and materials
The data that support the findings of this study are available on request
from the corresponding author [KS]. The data are not publicly available
because of information that could compromise research participant privacy.
Authors’ contributions
KJK and MBR designed the project. HAK contributed to planning, data
collection, and data cleaning. KS conducted the analysis with support from
MBR. KS, HAK and MBR drafted the manuscript. All authors contributed to
the manuscript with critical revisions and suggestions. All authors approved
the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The project was approved by The Regional Committees for Medical Research
Ethics and the Norwegian Social Science Data Services.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Head and Neck Research Group, Research Centre, Akershus University
Hospital, Lørenskog, Norway. 2Institute of Clinical Medicine, Campus Akershus
University Hospital, University of Oslo, Lørenskog, Norway. 3Department of
Pulmonary Medicine, Medical Division, Akershus University Hospital,
Lørenskog, Norway. 4Health Services Research Unit, Akershus University
Hospital, Lørenskog, Norway. 5Department of General Practice, University of
Oslo, Oslo, Norway. 6C3 Centre for Connected Care, Oslo University Hospital,
Oslo, Norway. 7BI Norwegian Business School, Oslo, Norway.
Received: 9 February 2017 Accepted: 7 March 2017
References
1. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R (2005) Secular changes
in health care utilization and work absence for migraine and tension-type
headache: a population based study. Eur J Epidemiol 20(12):1007–1014
2. Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J (1995) Prevalence and
sex-ratio of the subtypes of migraine. Int J Epidemiol 24(3):612–618
3. Russell MB, Levi N, Saltyte-Benth J, Fenger K (2006) Tension-type headache
in adolescents and adults: a population based study of 33,764 twins. Eur J
Epidemiol 21(2):153–160
4. Jensen R, Stovner LJ (2008) Epidemiology and comorbidity of headache.
Lancet Neurol 7(4):354–361
5. Grande RB, Aaseth K, Gulbrandsen P, Lundqvist C, Russell MB (2008)
Prevalence of primary chronic headache in a population-based sample of
30- to 44-year-old persons. The Akershus study of chronic headache.
Neuroepidemiology 30(2):76–83
6. Mitler MM, Carskadon MA, Czeisler CA, Dement WC, Dinges DF, Graeber RC
(1988) Catastrophes, sleep, and public policy: consensus report. Sleep 11(1):
100–109
7. Roth T, Roehrs TA (1996) Etiologies and sequelae of excessive daytime
sleepiness. Clin Ther 18(4):562–576, discussion 561
8. Leger D (1994) The cost of sleep-related accidents: a report for the national
commission on sleep disorders research. Sleep 17(1):84–93
9. Briones B, Adams N, Strauss M, Rosenberg C, Whalen C, Carskadon M,
Roebuck T, Winters M, Redline S (1996) Relationship between sleepiness
and general health status. Sleep 19(7):583–58810. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The
occurrence of sleep-disordered breathing among middle-aged adults. N
Engl J Med 328(17):1230–1235
11. Duran J, Esnaola S, Rubio R, Iztueta A (2001) Obstructive sleep apnea-
hypopnea and related clinical features in a population-based sample of
subjects aged 30 to 70 yr. Am J Respir Crit Care Med 163(3 Pt 1):685–689
12. Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A (2005)
Excessive daytime sleepiness in a general population sample: the role of
sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab
90(8):4510–4515
13. Stradling JR, Barbour C, Glennon J, Langford BA, Crosby JH (2000)
Prevalence of sleepiness and its relation to autonomic evidence of arousals
and increased inspiratory effort in a community based population of men
and women. J Sleep Res 9(4):381–388
14. Stiefel F, Stagno D (2004) Management of insomnia in patients with chronic
pain conditions. CNS Drugs 18(5):285–296
15. Young TB (2004) Epidemiology of daytime sleepiness: definitions,
symptomatology, and prevalence. J Clin Psychiatry 65(Suppl 16):12–16
16. Leger D, Poursain B, Neubauer D, Uchiyama M (2008) An international
survey of sleeping problems in the general population. Curr Med Res Opin
24(1):307–317
17. Peres MF, Stiles MA, Siow HC, Silberstein SD (2005) Excessive daytime
sleepiness in migraine patients. J Neurol Neurosurg Psychiatry 76(10):1467–
1468
18. Barbanti P, Fabbrini G, Aurilia C, Vanacore N, Cruccu G (2007) A case–control
study on excessive daytime sleepiness in episodic migraine. Cephalalgia
27(10):1115–1119
19. Seidel S, Hartl T, Weber M, Matterey S, Paul A, Riederer F, Gharabaghi M,
Wober-Bingol C, Wober C (2009) Quality of sleep, fatigue and daytime
sleepiness in migraine - a controlled study. Cephalalgia 29(6):662–669
20. Barbanti P, Aurilia C, Egeo G, Fofi L, Vanacore N (2013) A case–control study
on excessive daytime sleepiness in chronic migraine. Sleep Med 14(3):278–281
21. Ødegård SS, Engstrøm M, Sand T, Stovner LJ, Zwart JA, Hagen K (2010)
Associations between sleep disturbance and primary headaches: the third
Nord-Trondelag Health Study. J Headache Pain 11(3):197–206
22. Kim J, Cho SJ, Kim WJ, Yang KI, Yun CH, Chu MK (2016) Excessive daytime
sleepiness is associated with an exacerbation of migraine: A population-
based study. J Headache Pain 17(1):62
23. Russell MB, Kristiansen HA, Saltyte-Benth J, Kvaerner KJ (2008) A cross-
sectional population-based survey of migraine and headache in 21,177
Norwegians: the Akershus sleep apnea project. J Headache Pain 9(6):
339–347
24. Society HCSotIH (2004) The International Classification of Headache
Disorders: 2nd edition. Cephalalgia 24(Suppl 1):9–160
25. Johns MW (1991) A new method for measuring daytime sleepiness: the
Epworth sleepiness scale. Sleep 14(6):540–545
26. Johns MW (1994) Sleepiness in different situations measured by the
Epworth Sleepiness Scale. Sleep 17(8):703–710
27. Beiske KK, Kjelsberg FN, Ruud EA, Stavem K (2009) Reliability and validity of
a Norwegian version of the Epworth sleepiness scale. Sleep Breath
13(1):65–72
28. Whooley MA, Avins AL, Miranda J, Browner WS (1997) Case-finding
instruments for depression. Two questions are as good as many. J Gen
Intern Med 12(7):439–445
29. Pallesen S, Nordhus IH, Omvik S, Sivertsen B, Tell GS, Bjorvatn B (2007)
Prevalence and risk factors of subjective sleepiness in the general adult
population. Sleep 30(5):619–624
30. Vgontzas A, Cui L, Merikangas KR (2008) Are sleep difficulties associated
with migraine attributable to anxiety and depression? Headache 48(10):
1451–1459
31. Ancoli-Israel S, Roth T (1999) Characteristics of insomnia in the united states:
results of the 1991 national sleep foundation survey. I. Sleep 22(Suppl 2):
S347–353
32. Johns MW, Hocking B (1997) Daytime sleepiness and sleep habits of
Australian workers. Sleep 20(10):844–849
33. Gander PH, Marshall NS, Harris R, Reid P (2005) The Epworth sleepiness
scale: influence of age, ethnicity, and socioeconomic deprivation. Epworth
sleepiness scores of adults in New Zealand. Sleep 28(2):249–253
34. Sanford SD, Lichstein KL, Durrence HH, Riedel BW, Taylor DJ, Bush AJ (2006)
The influence of age, gender, ethnicity, and insomnia on Epworth
sleepiness scores: a normative US population. Sleep Med 7(4):319–326
Stavem et al. The Journal of Headache and Pain  (2017) 18:35 Page 9 of 935. Sander C, Hegerl U, Wirkner K, Walter N, Kocalevent RD, Petrowski K,
Glaesmer H, Hinz A (2016) Normative values of the Epworth sleepiness scale
(ESS), derived from a large German sample. Sleep Breath 20(4):1337–1345
36. Johns MW (1992) Reliability and factor analysis of the Epworth sleepiness
scale. Sleep 15(4):376–381
37. Olson LG, Cole MF, Ambrogetti A (1998) Correlations among Epworth
sleepiness scale scores, multiple sleep latency tests and psychological
symptoms. J Sleep Res 7(4):248–253
38. Chervin RD, Aldrich MS (1999) The Epworth Sleepiness Scale may not reflect
objective measures of sleepiness or sleep apnea. Neurology 52(1):125–131
39. Furuta H, Kaneda R, Kosaka K, Arai H, Sano J, Koshino Y (1999) Epworth
sleepiness scale and sleep studies in patients with obstructive sleep apnea
syndrome. Psychiatry Clin Neurosci 53(2):301–302
40. Rasmussen BK, Jensen R, Olesen J (1991) Questionnaire versus clinical
interview in the diagnosis of headache. Headache 31:290–295Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
